388 related articles for article (PubMed ID: 23891899)
1. Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.
Janes K; Doyle T; Bryant L; Esposito E; Cuzzocrea S; Ryerse J; Bennett GJ; Salvemini D
Pain; 2013 Nov; 154(11):2432-2440. PubMed ID: 23891899
[TBL] [Abstract][Full Text] [Related]
2. Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.
Zheng H; Xiao WH; Bennett GJ
Exp Neurol; 2011 Dec; 232(2):154-61. PubMed ID: 21907196
[TBL] [Abstract][Full Text] [Related]
3. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
Zheng H; Xiao WH; Bennett GJ
Exp Neurol; 2012 Dec; 238(2):225-34. PubMed ID: 22947198
[TBL] [Abstract][Full Text] [Related]
4. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.
Xiao WH; Zheng H; Bennett GJ
Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546
[TBL] [Abstract][Full Text] [Related]
5. Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.
Xiao WH; Bennett GJ
Pain; 2012 Mar; 153(3):704-709. PubMed ID: 22244441
[TBL] [Abstract][Full Text] [Related]
6. Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain.
Doyle T; Chen Z; Muscoli C; Bryant L; Esposito E; Cuzzocrea S; Dagostino C; Ryerse J; Rausaria S; Kamadulski A; Neumann WL; Salvemini D
J Neurosci; 2012 May; 32(18):6149-60. PubMed ID: 22553021
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.
Xiao WH; Zheng H; Zheng FY; Nuydens R; Meert TF; Bennett GJ
Neuroscience; 2011 Dec; 199():461-9. PubMed ID: 22037390
[TBL] [Abstract][Full Text] [Related]
8. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
[TBL] [Abstract][Full Text] [Related]
9. Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy.
Waseem M; Kaushik P; Tabassum H; Parvez S
Curr Drug Metab; 2018; 19(1):47-54. PubMed ID: 29219049
[TBL] [Abstract][Full Text] [Related]
10. Mini-Review: Mitochondrial dysfunction and chemotherapy-induced neuropathic pain.
Doyle TM; Salvemini D
Neurosci Lett; 2021 Aug; 760():136087. PubMed ID: 34182057
[TBL] [Abstract][Full Text] [Related]
11. Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca
Karlsson JOG; Jynge P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673932
[TBL] [Abstract][Full Text] [Related]
12. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
13. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat.
Robinson CR; Zhang H; Dougherty PM
Neuroscience; 2014 Aug; 274():308-17. PubMed ID: 24905437
[TBL] [Abstract][Full Text] [Related]
15. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.
Flatters SJL; Bennett GJ
Pain; 2006 Jun; 122(3):245-257. PubMed ID: 16530964
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):486-507. PubMed ID: 32394362
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
18. Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.
Ferrari LF; Chum A; Bogen O; Reichling DB; Levine JD
J Neurosci; 2011 Aug; 31(31):11404-10. PubMed ID: 21813700
[TBL] [Abstract][Full Text] [Related]
19. Protective Effect of a Mitochondria-Targeted Peptide against the Development of Chemotherapy-Induced Peripheral Neuropathy in Mice.
Toyama S; Shimoyama N; Szeto HH; Schiller PW; Shimoyama M
ACS Chem Neurosci; 2018 Jul; 9(7):1566-1571. PubMed ID: 29660270
[TBL] [Abstract][Full Text] [Related]
20. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
